Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 4

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Breast 4Gastrointestinal 3Dermatologic 3Gynecologic 2Sarcoma 1Head & Neck 1

Conditions

Breast Neoplasms 3Recurrence 1Breast Cancer Female 1

Interventions

Cyclophosphamide 423Trastuzumab 414Paclitaxel 375Docetaxel 314Capecitabine 266Letrozole 262Carboplatin 257Doxorubicin 213Tamoxifen 184Fulvestrant 176Epirubicin 176Radiotherapy 171Anastrozole 164pembrolizumab 152pertuzumab 147Surveys and Questionnaires 146Exercise 142exemestane 128Vinorelbine 127palbociclib 124Bevacizumab 123Magnetic Resonance Spectroscopy 120Blood Specimen Collection 120Drug Therapy 106Albumin-Bound Paclitaxel 105Gemcitabine 99130-nm albumin-bound paclitaxel 98pyrotinib 92eribulin 90Biopsy 88

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Electrochemotherapy × Breast × Clear all
NCT06709937 2024-11-29

GISEL

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Completed
200 enrolled
Breast

Breast Cancer Female

NCT06683404 2024-11-12

GISEL

Istituto Oncologico Veneto IRCCS

Completed
205 enrolled
Breast

Breast Neoplasms

NCT01479946 2014-12-09

Electrochemotherapy For The Treatment Of Breast Cancer That Has Spread to the Skin

Uppsala University Hospital

Phase 2 Withdrawn
Breast

Breast Neoplasms

NCT00744653 2014-07-18

Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects.

Copenhagen University Hospital at Herlev

Phase 2 Terminated
17 enrolled 6 charts
Breast

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡